“ ‘Poverty is fought with health, education and, above all, employment and more employment’. This is the vision Carlos Slim has for Mexico. The CEO of the… ”
In Conversation
“ The general manager for Mexico, Central America and Caribbean shares his point of view about the announced healthcare reform, the opportunities and challenges it presents and… ”
“ Flor de María Philipps, Superintendent of Susalud, discusses her role in ensuring that healthcare providers throughout Peru are performing to the best of their ability. ”
“ Worldwide, Bayer is experiencing a strong business momentum thanks to an avalanche of innovation. The general manager of Bayer HealthCare Pharmaceuticals in Mexico shares his perspectives… ”
“ After Brazil, Torrent is looking to strengthen its foothold in the Mexican market. The general manager of the local affiliate explains the opportunities Latin America offers… ”
“ The current negotiations for the Trans-Pacific Partnership (TPP) provide Mexico with a not-to-be-missed opportunity to review the country’s intellectual property system. The partner of the life… ”
“ The director general of Afric-Phar explains why it is difficult for the local players to compete with multinationals, how the Moroccan market is being reformed for… ”
“ The director general of Promopharm explains why Hikma decided to invest in the Moroccan market, why we have to take a long-term perspective when judging the… ”
“ The president and director general of Sanofi Morocco talks about the impact of public/private partnerships for the development of the Moroccan health sector, explains why 2013… ”
“ Morocco has become GSK's regional hub thanks to the quality of human capital in the country, explains the company's area director, president and general manager for North Africa,… ”
“ Ralf Halbach discusses the impact of low health coverage in Morocco on Roche's strategy, and the fact that the company chose Morocco as the country to… ”
“ The country president and general director of Novartis Morocco discusses the impact of the price cuts on the pharma market, the need to change the health… ”
